FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Irwin Lucki

Research Profile

Living Beings

Activities & Behaviors

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Darrick T Balu; Julie A Blendy; Bethany R Brookshire; Tiffany E Hill-Smith; Jill R Turner; Irwin Lucki
Brain monoamines and antidepressant-like responses in MRL/MpJ versus C57BL/6J mice.
G E Hodes; O Berton; B R Brookshire; T E Hill-Smith; S L Teegarden; Irwin Lucki
Strain differences in the effects of chronic corticosterone exposure in the hippocampus.
Julie Espallergues; Chang-Gyu Hahn; Jeanine Jochems; Irwin Lucki; Patrick Matthias; Tess Petersen; Sarah L Teegarden; Avin Veerakumar; Janette Boulden; Collin Challis; Michael Chan; Evan Deneris; Sheryl G Beck; Olivier Berton
HDAC6 regulates glucocorticoid receptor signaling in serotonin pathways with critical impact on stress resilience.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Irwin Lucki (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Darrick T Balu; Julie A Blendy; Bethany R Brookshire; Tiffany E Hill-Smith; Jill R Turner; Irwin Lucki
Brain monoamines and antidepressant-like responses in MRL/MpJ versus C57BL/6J mice.
Neuropharmacology 2013;67():503-10.
2012: G E Hodes; O Berton; B R Brookshire; T E Hill-Smith; S L Teegarden; Irwin Lucki
Strain differences in the effects of chronic corticosterone exposure in the hippocampus.
Neuroscience 2012;222():269-80.
2012: Julie Espallergues; Chang-Gyu Hahn; Jeanine Jochems; Irwin Lucki; Patrick Matthias; Tess Petersen; Sarah L Teegarden; Avin Veerakumar; Janette Boulden; Collin Challis; Michael Chan; Evan Deneris; Sheryl G Beck; Olivier Berton
HDAC6 regulates glucocorticoid receptor signaling in serotonin pathways with critical impact on stress resilience.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2012;32(13):4400-16.
2012: Darrick T Balu; Morris J Birnbaum; Gregory C Carlson; Rachel M Easton; Tiffany E Hill-Smith; Hala Kazi; Konrad Talbot; Irwin Lucki
Akt1 deficiency in schizophrenia and impairment of hippocampal plasticity and function.
Hippocampus 2012;22(2):230-40.
2011: Julia W Cohen; Natalia Louneva; Li-Ying Han; Georgia E Hodes; Robert S Wilson; David A Bennett; Irwin Lucki; Steven E Arnold
Chronic corticosterone exposure alters postsynaptic protein levels of PSD-95, NR1, and synaptopodin in the mouse brain.
Synapse (New York, N.Y.) 2011;65(8):763-70.
2011: Philip J Cowen; Irwin Lucki
Serotonin revisited.
Psychopharmacology 2011;213(2-3):167-9.
2011: Gregory V Carr; Irwin Lucki
The role of serotonin receptor subtypes in treating depression: a review of animal studies.
Psychopharmacology 2011;213(2-3):265-87.
2011: Gregory V Carr; Lee E Schechter; Irwin Lucki
Antidepressant and anxiolytic effects of selective 5-HT6 receptor agonists in rats.
Psychopharmacology 2011;213(2-3):499-507.
2010: Georgia E Hodes; Tiffany E Hill-Smith; Irwin Lucki
Fluoxetine treatment induces dose dependent alterations in depression associated behavior and neural plasticity in female mice.
Neuroscience letters 2010;484(1):12-6.
2010: Michaux Kilpatrick; Ephraim Church; Shabbar Danish; Michael Stiefel; Jurg Jaggi; Casey Halpern; Marie Kerr; Eileen Maloney; Michael Robinson; Irwin Lucki; Elizabeth Krizman-Grenda; Gordon Baltuch
Intracerebral microdialysis during deep brain stimulation surgery.
Journal of neuroscience methods 2010;190(1):106-11.
2010: Z Vucetic; K Totoki; H Schoch; K W Whitaker; T Hill-Smith; Irwin Lucki; T M Reyes
Early life protein restriction alters dopamine circuitry.
Neuroscience 2010;168(2):359-70.
2010: Gregory V Carr; Irwin Lucki
Comparison of the kappa-opioid receptor antagonist DIPPA in tests of anxiety-like behavior between Wistar Kyoto and Sprague Dawley rats.
Psychopharmacology 2010;210(2):295-302.
2010: Rita J Valentino; Irwin Lucki; Elisabeth Van Bockstaele
Corticotropin-releasing factor in the dorsal raphe nucleus: Linking stress coping and addiction.
Brain research 2010;1314():29-37.
2010: Gregory V Carr; Debra A Bangasser; Thelma Bethea; Matthew Young; Rita J Valentino; Irwin Lucki
Antidepressant-like effects of kappa-opioid receptor antagonists in Wistar Kyoto rats.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2010;35(3):752-63.
2010: Georgia E Hodes; Tiffany E Hill-Smith; Raymond F Suckow; Thomas B Cooper; Irwin Lucki
Sex-specific effects of chronic fluoxetine treatment on neuroplasticity and pharmacokinetics in mice.
The Journal of pharmacology and experimental therapeutics 2010;332(1):266-73.
2009: Darrick T Balu; Georgia E Hodes; Brian T Anderson; Irwin Lucki
Enhanced sensitivity of the MRL/MpJ mouse to the neuroplastic and behavioral effects of chronic antidepressant treatments.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2009;34(7):1764-73.
2009: Jonathan Savitz; Irwin Lucki; Wayne C Drevets
5-HT(1A) receptor function in major depressive disorder.
Progress in neurobiology 2009;88(1):17-31.
2009: Darrick T Balu; Georgia E Hodes; Tiffany E Hill; Nancy Ho; Zia Rahman; Corey N Bender; Robert H Ring; Jason M Dwyer; Sharon Rosenzweig-Lipson; Zoe A Hughes; Lee E Schechter; Irwin Lucki
Flow cytometric analysis of BrdU incorporation as a high-throughput method for measuring adult neurogenesis in the mouse.
Journal of pharmacological and toxicological methods 2009;59(2):100-7.
2009: Darrick T Balu; Irwin Lucki
Adult hippocampal neurogenesis: regulation, functional implications, and contribution to disease pathology.
Neuroscience and biobehavioral reviews 2009;33(3):232-52.
2008: Brian A Hoshaw; Tiffany I Hill; James J Crowley; Jessica Malberg; Xavier Khawaja; Sharon Rosenzweig-Lipson; Lee E Schechter; Irwin Lucki
Antidepressant-like behavioral effects of IGF-I produced by enhanced serotonin transmission.
European journal of pharmacology 2008;594(1-3):109-16.
2008: James J Crowley; Robert H Lipsky; Irwin Lucki; Wade H Berrettini
Variation in the genes encoding vesicular monoamine transporter 2 and beta-1 adrenergic receptor and antidepressant treatment outcome.
Psychiatric genetics 2008;18(5):248-51.
2008: Owen Howard; Gregory Carr; Tiffany E Hill; Rita J Valentino; Irwin Lucki
Differential blockade of CRF-evoked behaviors by depletion of norepinephrine and serotonin in rats.
Psychopharmacology 2008;199(4):569-82.
2008: Anita J Bechtholt; Rita J Valentino; Irwin Lucki
Overlapping and distinct brain regions associated with the anxiolytic effects of chlordiazepoxide and chronic fluoxetine.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008;33(9):2117-30.
2008: Darrick T Balu; Brian A Hoshaw; Jessica Malberg; Sharon Rosenzweig-Lipson; Lee E Schechter; Irwin Lucki
Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments.
Brain research 2008;1211():37-43.
2008: Anita J Bechtholt; Karen Smith; Stephanie Gaughan; Irwin Lucki
Sucrose intake and fasting glucose levels in 5-HT(1A) and 5-HT(1B) receptor mutant mice.
Physiology & behavior 2008;93(4-5):659-65.
2007: Jessica Malberg; Brian Platt; Stacey J Sukoff Rizzo; Robert H Ring; Irwin Lucki; Lee E Schechter; Sharon Rosenzweig-Lipson
Increasing the levels of insulin-like growth factor-I by an IGF binding protein inhibitor produces anxiolytic and antidepressant-like effects.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2007;32(11):2360-8.
2007: Tamar L Gur; Alana C Conti; Jessica Holden; Anita J Bechtholt; Tiffany E Hill; Irwin Lucki; Jessica Malberg; Julie A Blendy
cAMP response element-binding protein deficiency allows for increased neurogenesis and a rapid onset of antidepressant response.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2007;27(29):7860-8.
2007: Olivia F O'Leary; Anita J Bechtholt; James J Crowley; Tiffany E Hill; Michelle E Page; Irwin Lucki
Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test.
Psychopharmacology 2007;192(3):357-71.
2007: Sharon Rosenzweig-Lipson; Annmarie L Sabb; Gary Stack; Paul Mitchell; Irwin Lucki; Jessica Malberg; Steven M Grauer; Julie Brennan; John Cryan; Stacey J Sukoff Rizzo; John Dunlop; James E Barrett; Karen L Marquis
Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents.
Psychopharmacology 2007;192(2):159-70.
2007: Anita J Bechtholt; Tiffany E Hill; Irwin Lucki
Anxiolytic effect of serotonin depletion in the novelty-induced hypophagia test.
Psychopharmacology 2007;190(4):531-40.
2007: Olivia F O'Leary; Anita J Bechtholt; James J Crowley; Rita J Valentino; Irwin Lucki
The role of noradrenergic tone in the dorsal raphe nucleus of the mouse in the acute behavioral effects of antidepressant drugs.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2007;17(3):215-26.
2006: Brian A Hoshaw; Jennifer C Evans; Bridget Mueller; Rita J Valentino; Irwin Lucki
Social competition in rats: cell proliferation and behavior.
Behavioural brain research 2006;175(2):343-51.
2006: James J Crowley; Edward S Brodkin; Julie A Blendy; Wade H Berrettini; Irwin Lucki
Pharmacogenomic evaluation of the antidepressant citalopram in the mouse tail suspension test.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(11):2433-42.
2005: James J Crowley; Julie A Blendy; Irwin Lucki
Strain-dependent antidepressant-like effects of citalopram in the mouse tail suspension test.
Psychopharmacology 2005;183(2):257-64.
2005: John Cryan; Michelle E Page; Irwin Lucki
Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment.
Psychopharmacology 2005;182(3):335-44.
2005: Michelle D Jones; Irwin Lucki
Sex differences in the regulation of serotonergic transmission and behavior in 5-HT receptor knockout mice.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2005;30(6):1039-47.
2005: Brian A Hoshaw; Jessica Malberg; Irwin Lucki
Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects.
Brain research 2005;1037(1-2):204-8.
2005: Christine M Andrews; Hank F Kung; Irwin Lucki
The 5-HT1A receptor modulates the effects of cocaine on extracellular serotonin and dopamine levels in the nucleus accumbens.
European journal of pharmacology 2005;508(1-3):123-30.
2005: John Cryan; Rita J Valentino; Irwin Lucki
Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test.
Neuroscience and biobehavioral reviews 2005;29(4-5):547-69.
2005: James J Crowley; Irwin Lucki
Opportunities to discover genes regulating depression and antidepressant response from rodent behavioral genetics.
Current pharmaceutical design 2005;11(2):157-69.
2004: James J Crowley; Michelle D Jones; Olivia F O'Leary; Irwin Lucki
Automated tests for measuring the effects of antidepressants in mice.
Pharmacology, biochemistry, and behavior 2004;78(2):269-74.
2004: John Cryan; Olivia F O'Leary; Sung-Ha Jin; Julie C Friedland; Ming Ouyang; Bradford R Hirsch; Michelle E Page; Ashutosh Dalvi; Steven A Thomas; Irwin Lucki
Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(21):8186-91.
2004: Patricia M Furlan; Michael J Kallan; Thomas Ten Have; Irwin Lucki; Ira Katz
SSRIs do not cause affective blunting in healthy elderly volunteers.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2004;12(3):323-30.
2004: Irwin Lucki; Olivia F O'Leary
Distinguishing roles for norepinephrine and serotonin in the behavioral effects of antidepressant drugs.
The Journal of clinical psychiatry 2004;65 Suppl 4():11-24.
2003: Earl Thomas; Luise Pernar; Irwin Lucki; Rita J Valentino
Corticotropin-releasing factor in the dorsal raphe nucleus regulates activity of lateral septal neurons.
Brain research 2003;960(1-2):201-8.
2003: Michelle E Page; Kevin Brown; Irwin Lucki
Simultaneous analyses of the neurochemical and behavioral effects of the norepinephrine reuptake inhibitor reboxetine in a rat model of antidepressant action.
Psychopharmacology 2003;165(2):194-201.
2002: Michelle E Page; John Cryan; Arthur Sullivan; Ashutosh Dalvi; Berangere Saucy; David R Manning; Irwin Lucki
Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
The Journal of pharmacology and experimental therapeutics 2002;302(3):1220-7.
2002: Michelle L Price; Lynn G Kirby; Rita J Valentino; Irwin Lucki
Evidence for corticotropin-releasing factor regulation of serotonin in the lateral septum during acute swim stress: adaptation produced by repeated swimming.
Psychopharmacology 2002;162(4):406-14.
2002: Michelle E Page; Irwin Lucki
Effects of acute and chronic reboxetine treatment on stress-induced monoamine efflux in the rat frontal cortex.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;27(2):237-47.
2002: John Cryan; Athina Markou; Irwin Lucki
Assessing antidepressant activity in rodents: recent developments and future needs.
Trends in pharmacological sciences 2002;23(5):238-45.
2002: Alana C Conti; John Cryan; Ashutosh Dalvi; Irwin Lucki; Julie A Blendy
cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2002;22(8):3262-8.
2002: Peter A Rittenhouse; Carolina López-Rubalcava; Gregg D Stanwood; Irwin Lucki
Amplified behavioral and endocrine responses to forced swim stress in the Wistar-Kyoto rat.
Psychoneuroendocrinology 2002;27(3):303-18.
2002: John Cryan; Michelle E Page; Irwin Lucki
Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test.
European journal of pharmacology 2002;436(3):197-205.
2002: Laurel A Graves; Ashutosh Dalvi; Irwin Lucki; Julie A Blendy; Ted Abel
Behavioral analysis of CREB alphadelta mutation on a B6/129 F1 hybrid background.
Hippocampus 2002;12(1):18-26.
2001: AJ Mayorga; Ashutosh Dalvi; Michelle E Page; S Zimov-Levinson; R Hen; Irwin Lucki
Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant mice.
The Journal of pharmacology and experimental therapeutics 2001;298(3):1101-7.
2001: DA Knobelman; R Hen; Julie A Blendy; Irwin Lucki
Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse.
The Journal of pharmacology and experimental therapeutics 2001;298(3):1092-100.
2001: DA Knobelman; R Hen; Irwin Lucki
Genetic regulation of extracellular serotonin by 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) autoreceptors in different brain regions of the mouse.
The Journal of pharmacology and experimental therapeutics 2001;298(3):1083-91.
2001: Patricia M Furlan; N DeMartinis; Edward Schweizer; Karl Rickels; Irwin Lucki
Abnormal salivary cortisol levels in social phobic patients in response to acute psychological but not physical stress.
Biological psychiatry 2001;50(4):254-9.
2001: John Cryan; Ashutosh Dalvi; Sung-Ha Jin; B R Hirsch; Irwin Lucki; Steven A Thomas
Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs.
The Journal of pharmacology and experimental therapeutics 2001;298(2):651-7.
2001: Irwin Lucki; Ashutosh Dalvi; AJ Mayorga
Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice.
Psychopharmacology 2001;155(3):315-22.
2001: C M Andrews; Irwin Lucki
Effects of cocaine on extracellular dopamine and serotonin levels in the nucleus accumbens.
Psychopharmacology 2001;155(3):221-9.
2001: Michelle L Price; Irwin Lucki
Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2001;21(8):2833-41.
2001: AJ Mayorga; Irwin Lucki
Limitations on the use of the C57BL/6 mouse in the tail suspension test.
Psychopharmacology 2001;155(1):110-2.
2001: Patricia M Furlan; Michael J Kallan; Thomas R Ten Have; B G Pollock; Ira Katz; Irwin Lucki
Cognitive and psychomotor effects of paroxetine and sertraline on healthy elderly volunteers.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2001;9(4):429-38.
2000: John Cryan; Irwin Lucki
5-HT4 receptors do not mediate the antidepressant-like behavioral effects of fluoxetine in a modified forced swim test.
European journal of pharmacology 2000;409(3):295-9.
2000: Gregg D Stanwood; Irwin Lucki; P McGonigle
Differential regulation of dopamine D2 and D3 receptors by chronic drug treatments.
The Journal of pharmacology and experimental therapeutics 2000;295(3):1232-40.
2000: Gregg D Stanwood; R P Artymyshyn; Mei-Ping Kung; Hank F Kung; Irwin Lucki; P McGonigle
Quantitative autoradiographic mapping of rat brain dopamine D3 binding with [(125)I]7-OH-PIPAT: evidence for the presence of D3 receptors on dopaminergic and nondopaminergic cell bodies and terminals.
The Journal of pharmacology and experimental therapeutics 2000;295(3):1223-31.
2000: John Cryan; Irwin Lucki
Antidepressant-like behavioral effects mediated by 5-Hydroxytryptamine(2C) receptors.
The Journal of pharmacology and experimental therapeutics 2000;295(3):1120-6.
2000: Jing Yang; Jie Wu; M A Kowalska; Ashutosh Dalvi; Nicolas Prévost; Peter J O'Brien; D Manning; Mortimer Poncz; Irwin Lucki; Julie A Blendy; Lawrence F Brass
Loss of signaling through the G protein, Gz, results in abnormal platelet activation and altered responses to psychoactive drugs.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(18):9984-9.
2000: Steven Troy; Irwin Lucki; M A Unruh; WH Cevallos; CA Leister; PT Martin; Patricia M Furlan; Richard Mangano
Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance.
Journal of clinical psychopharmacology 2000;20(3):328-37.
2000: DA Knobelman; Hank F Kung; Irwin Lucki
Regulation of extracellular concentrations of 5-hydroxytryptamine (5-HT) in mouse striatum by 5-HT(1A) and 5-HT(1B) receptors.
The Journal of pharmacology and experimental therapeutics 2000;292(3):1111-7.
2000: Carolina López-Rubalcava; Irwin Lucki
Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2000;22(2):191-9.
1999: Michelle E Page; Michael Detke; Ashutosh Dalvi; Lynn G Kirby; Irwin Lucki
Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test.
Psychopharmacology 1999;147(2):162-7.
1999: Ashutosh Dalvi; Irwin Lucki
Murine models of depression.
Psychopharmacology 1999;147(1):14-6.
1999: Karl Rickels; Irwin Lucki; Edward Schweizer; Felipe García-España; W G Case
Psychomotor performance of long-term benzodiazepine users before, during, and after benzodiazepine discontinuation.
Journal of clinical psychopharmacology 1999;19(2):107-13.
1998: Lynn G Kirby; Irwin Lucki
The effect of repeated exposure to forced swimming on extracellular levels of 5-hydroxytryptamine in the rat.
Stress (Amsterdam, Netherlands) 1998;2(4):251-63.
1998: Irwin Lucki
The spectrum of behaviors influenced by serotonin.
Biological psychiatry 1998;44(3):151-62.
1998: Michelle L Price; Andre L Curtis; Lynn G Kirby; Rita J Valentino; Irwin Lucki
Effects of corticotropin-releasing factor on brain serotonergic activity.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1998;18(6):492-502.
1998: J P Rénéric; Irwin Lucki
Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test.
Psychopharmacology 1998;136(2):190-7.
1997: Lynn G Kirby; Irwin Lucki
Interaction between the forced swimming test and fluoxetine treatment on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the rat.
The Journal of pharmacology and experimental therapeutics 1997;282(2):967-76.
1997: Lynn G Kirby; J M Chou-Green; K Davis; Irwin Lucki
The effects of different stressors on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid.
Brain research 1997;760(1-2):218-30.
1997: Michael Detke; J Johnson; Irwin Lucki
Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression.
Experimental and clinical psychopharmacology 1997;5(2):107-12.
1997: A R Allen; A Singh; Zhi-Ping Zhuang; Mei-Ping Kung; Hank F Kung; Irwin Lucki
The 5-HT1A receptor antagonist p-MPPI blocks responses mediated by postsynaptic and presynaptic 5-HT1A receptors.
Pharmacology, biochemistry, and behavior 1997;57(1-2):301-7.
1997: D S Kreiss; Irwin Lucki
Chronic administration of the 5-HT1A receptor agonist 8-OH-DPAT differentially desensitizes 5-HT1A autoreceptors of the dorsal and median raphe nuclei.
Synapse (New York, N.Y.) 1997;25(2):107-16.
1996: K Eberle-Wang; Irwin Lucki; Marie-Francoise Chesselet
A role for the subthalamic nucleus in 5-HT2C-induced oral dyskinesia.
Neuroscience 1996;72(1):117-28.
1996: J L Neisewander; Irwin Lucki; P McGonigle
Changes in behavioral sensitivity to SKF-38393 and quinpirole following withdrawal from continuous cocaine administration in rats.
Pharmacology, biochemistry, and behavior 1996;53(4):935-42.
1996: J S Shumsky; Irwin Lucki
Differential tolerance to the effects of chlordiazepoxide on unpunished and punished operant responding following chronic treatment.
Pharmacology, biochemistry, and behavior 1996;53(3):593-601.
1996: M Mercugliano; H Nguyen; S Djali; Irwin Lucki
Developmental alterations in 5-hydroxytryptamine concentration and turnover after treatment of neonatal rats with 5,7-dihydroxytryptamine.
Neurobiology of learning and memory 1996;65(2):163-76.
1996: Michael Detke; Irwin Lucki
Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth.
Behavioural brain research 1996;73(1-2):43-6.
1996: Irwin Lucki
Serotonin receptor specificity in anxiety disorders.
The Journal of clinical psychiatry 1996;57 Suppl 6():5-10.
1995: Michael Detke; M Rickels; Irwin Lucki
Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants.
Psychopharmacology 1995;121(1):66-72.
1995: D S Kreiss; Irwin Lucki
Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo.
The Journal of pharmacology and experimental therapeutics 1995;274(2):866-76.
1995: Mei-Ping Kung; W D Essman; D Frederick; SK Meegalla; Mark M Goodman; M Mu; Irwin Lucki; Hank F Kung
IPT: a novel iodinated ligand for the CNS dopamine transporter.
Synapse (New York, N.Y.) 1995;20(4):316-24.
1995: Lynn G Kirby; A R Allen; Irwin Lucki
Regional differences in the effects of forced swimming on extracellular levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid.
Brain research 1995;682(1-2):189-96.
1995: L G Kirby; D S Kreiss; A Singh; Irwin Lucki
Effect of destruction of serotonin neurons on basal and fenfluramine-induced serotonin release in striatum.
Synapse (New York, N.Y.) 1995;20(2):99-105.
1995: Michael Detke; S Wieland; Irwin Lucki
Blockade of the antidepressant-like effects of 8-OH-DPAT, buspirone and desipramine in the rat forced swim test by 5HT1A receptor antagonists.
Psychopharmacology 1995;119(1):47-54.
1994: W D Essman; A Singh; Irwin Lucki
Serotonergic properties of cocaine: effects on a 5-HT2 receptor-mediated behavior and on extracellular concentrations of serotonin and dopamine.
Pharmacology, biochemistry, and behavior 1994;49(1):107-13.
1994: T J Parry; K Eberle-Wang; Irwin Lucki; Marie-Francoise Chesselet
Dopaminergic stimulation of subthalamic nucleus elicits oral dyskinesia in rats.
Experimental neurology 1994;128(2):181-90.
1994: D S Kreiss; Irwin Lucki
Differential regulation of serotonin (5-HT) release in the striatum and hippocampus by 5-HT1A autoreceptors of the dorsal and median raphe nuclei.
The Journal of pharmacology and experimental therapeutics 1994;269(3):1268-79.
1994: J S Shumsky; Irwin Lucki
Differential regulation of the behavioral effects of chlordiazepoxide.
Psychopharmacology 1994;115(1-2):37-45.
1994: Irwin Lucki; A Singh; D S Kreiss
Antidepressant-like behavioral effects of serotonin receptor agonists.
Neuroscience and biobehavioral reviews 1994;18(1):85-95.
1994: J L Neisewander; Irwin Lucki; P McGonigle
Time-dependent changes in sensitivity to apomorphine and monoamine receptors following withdrawal from continuous cocaine administration in rats.
Synapse (New York, N.Y.) 1994;16(1):1-10.
1994: L G Kirby; G A Rowan; R L Smith; Irwin Lucki
Discriminative stimulus properties of the benzodiazepine receptor inverse agonist methyl-6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM).
Psychopharmacology 1994;113(3-4):351-60.
1993: S Wieland; C T Fischette; Irwin Lucki
Effect of chronic treatments with tandospirone and imipramine on serotonin-mediated behavioral responses and monoamine receptors.
Neuropharmacology 1993;32(6):561-73.
1993: A Singh; Irwin Lucki
Antidepressant-like activity of compounds with varying efficacy at 5-HT1A receptors.
Neuropharmacology 1993;32(4):331-40.
1993: Bethany Neal-Beliveau; Jeffrey N. Joyce; Irwin Lucki
Serotonergic involvement in haloperidol-induced catalepsy.
The Journal of pharmacology and experimental therapeutics 1993;265(1):207-17.
1993: K Raynor; Irwin Lucki; Terry Reisine
Somatostatin receptors in the nucleus accumbens selectively mediate the stimulatory effect of somatostatin on locomotor activity in rats.
The Journal of pharmacology and experimental therapeutics 1993;265(1):67-73.
1993: W D Essman; P McGonigle; Irwin Lucki
Anatomical differentiation within the nucleus accumbens of the locomotor stimulatory actions of selective dopamine agonists and d-amphetamine.
Psychopharmacology 1993;112(2-3):233-41.
1993: D S Kreiss; S Wieland; Irwin Lucki
The presence of a serotonin uptake inhibitor alters pharmacological manipulations of serotonin release.
Neuroscience 1993;52(2):295-301.
1992: D S Kreiss; Irwin Lucki
Desensitization of 5-HT1A autoreceptors by chronic administration of 8-OH-DPAT.
Neuropharmacology 1992;31(10):1073-6.
1992: S Subramaniam; Irwin Lucki; P McGonigle
Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
Brain research 1992;571(2):313-22.
1992: Irwin Lucki
5-HT1 receptors and behavior.
Neuroscience and biobehavioral reviews 1992;16(1):83-93.
1992: G A Rowan; Irwin Lucki
Discriminative stimulus properties of the benzodiazepine receptor antagonist flumazenil.
Psychopharmacology 1992;107(1):103-12.
1991: Irwin Lucki
Behavioral studies of serotonin receptor agonists as antidepressant drugs.
The Journal of clinical psychiatry 1991;52 Suppl():24-31.
1991: J L Neisewander; Irwin Lucki; P McGonigle
Neurochemical changes associated with the persistence of spontaneous oral dyskinesia in rats following chronic reserpine treatment.
Brain research 1991;558(1):27-35.
1991: J L Neisewander; Irwin Lucki; P McGonigle
Behavioral and neurochemical effects of chronic administration of reserpine and SKF-38393 in rats.
The Journal of pharmacology and experimental therapeutics 1991;257(2):850-60.
1990: Irwin Lucki; S Wieland
5-Hydroxytryptamine1A receptors and behavioral responses.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1990;3(5-6):481-93.
1990: S Wieland; M S Kreider; P McGonigle; Irwin Lucki
Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridine.
Brain research 1990;520(1-2):291-302.
1990: Irwin Lucki; R F Kucharik
Increased sensitivity to benzodiazepine antagonists in rats following chronic treatment with a low dose of diazepam.
Psychopharmacology 1990;102(3):350-6.
1990: S Wieland; Irwin Lucki
Antidepressant-like activity of 5-HT1A agonists measured with the forced swim test.
Psychopharmacology 1990;101(4):497-504.
1990: Irwin Lucki; Joseph Robert Volpicelli; Edward Schweizer
Differential craving between recovering abstinent alcoholic-dependent subjects and therapeutic users of benzodiazepines.
NIDA research monograph 1990;105():322-3.
1989: S Wieland; D Goodale; Irwin Lucki
Behavioral effects of 8-OH-DPAT: studies using the Microtaxic ventricular injector.
Journal of neuroscience methods 1989;30(2):151-9.
1989: Irwin Lucki; H R Ward; Alan Frazer
Effect of 1-(m-chlorophenyl)piperazine and 1-(m-trifluoromethylphenyl)piperazine on locomotor activity.
The Journal of pharmacology and experimental therapeutics 1989;249(1):155-64.
1989: Irwin Lucki; L A Kerr; R B Fridman; Edward Schweizer; Karl Rickels
Behavioral effects of alprazolam in chronic therapeutic users.
NIDA research monograph 1989;95():464.
1989: G A Rowan; Irwin Lucki
Discrimination of the benzodiazepine receptor antagonist Ro 15-1788 using the conditioned taste aversion procedure.
NIDA research monograph 1989;95():536.
1988: Irwin Lucki
Rapid discrimination of the stimulus properties of 5-hydroxytryptamine agonists using conditioned taste aversion.
The Journal of pharmacology and experimental therapeutics 1988;247(3):1120-7.
1988: Richard Doty; M Ferguson-Segall; Irwin Lucki; M Kreider
Effects of intrabulbar injections of 6-hydroxydopamine on ethyl acetate odor detection in castrate and non-castrate male rats.
Brain research 1988;444(1):95-103.
1988: Irwin Lucki; M S Kreider; Kenny J Simansky
Reduction of feeding behavior by the serotonin uptake inhibitor sertraline.
Psychopharmacology 1988;96(3):289-95.
1988: Irwin Lucki; Karl Rickels
The effect of anxiolytic drugs on memory in anxious subjects.
Psychopharmacology series 1988;6():128-39.
1987: Irwin Lucki; N Minugh-Purvis
Serotonin-induced head shaking behavior in rats does not involve receptors located in the frontal cortex.
Brain research 1987;420(2):403-6.